丙基硫氧嘧啶
体内
甲状腺球蛋白
硫氧嘧啶
内科学
内分泌学
化学
体外
生物合成
碘
甲状腺
抗甲状腺药
生物化学
酶
医学
生物
格雷夫斯病
有机化学
生物技术
作者
Fabrizio Monaco,C. Santolamazza,I. De Ros,A. Andréoli
出处
期刊:European journal of endocrinology
[Bioscientifica]
日期:1980-01-01
卷期号:93 (1): 32-36
被引量:15
标识
DOI:10.1530/acta.0.0930032
摘要
The effect of 6-propyl-2-thiouracil (PTU), and 1-methyl-2-mercaptoimidazole (MMI) on thyroglobulin (Tg) biosynthesis has been studied in vivo and in vitro. In vivo experiments were performed in rats treated for 20 days with PTU or MMI, analyzing soluble and particulate, cold and 125I-labelled, Tg. Thyroglobulin biosynthesis was also investigated by in vitro experiments, incubating thyroid tissue with labelled amino acid and carbohydrate in the presence of antithyroid compounds. It has been found that in vivo antithyroid agents decrease the amount of soluble Tg and increase the proportion of particulate Tg. Tg from treated animals is poorly iodinated being mainly represented by its 12S subunit. In vitro studies demonstrate that PTU and MMI inhibit Tg biosynthesis which is impaired in the polypeptide synthesis as well as in carbohydrate chains addition. Thus the inhibition of the hormonogenetic processes induced by antithyroid treatment leading to a depressed iodinating activity also appears to be related to a significant impairment of the production of the Tg molecule, the specific iodine acceptor.
科研通智能强力驱动
Strongly Powered by AbleSci AI